Table 4.
The clinical parameters of matched groups with different metastases.
| With bone/liver metastases (n = 297) | With metastases other than bone/liver (n = 297) | P | ||
|---|---|---|---|---|
| Age | ||||
| Median (range) | 64 (39–93) | 63 (39–91) | 65 (41–93) | |
| <70 | 500 | 251 | 249 | 0.822 |
| ≥70 | 94 | 46 | 48 | |
| Gender | ||||
| Male | 452 | 231 | 221 | 0.336 |
| Female | 142 | 66 | 76 | |
| Race | ||||
| White | 259 | 182 | 177 | 0.313 |
| Black | 161 | 84 | 77 | |
| Others | 74 | 31 | 43 | |
| T | ||||
| T1–2 | 365 | 184 | 181 | 0.800 |
| T3–4 | 229 | 113 | 116 | |
| N | ||||
| N0 | 164 | 75 | 89 | 0.199 |
| N+ | 430 | 222 | 208 | |
| Metastases at diagnosis | ||||
| Brain metastases | 15 | 6 | 9 | 0.433 |
| No brain metastases | 579 | 291 | 288 | |
| Lung metastases | 214 | 99 | 115 | 0.171 |
| No lung metastases | 380 | 198 | 182 | |